Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1988 1
1989 1
1991 1
1992 1
1993 4
1994 5
1995 3
1996 1
1998 3
2000 1
2001 1
2002 4
2003 2
2004 5
2005 8
2006 7
2007 9
2008 9
2009 1
2010 7
2011 4
2012 4
2013 2
2014 2
2015 4
2016 6
2017 2
2018 7
2019 14
2020 37
2021 12
2022 10
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Results by year

Filters applied: . Clear all
Page 1
Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB, Amnerkar ND, Ramesh B, Tambuwala MM, Bakshi HA, Aljabali AAA, Khadse SC, Satheeshkumar R, Satija S, Metha M, Chellappan DK, Shrivastava G, Gupta G, Negi P, Dua K, Zacconi FC. Charbe NB, et al. Among authors: satija s. Acta Pharm Sin B. 2020 Nov;10(11):2075-2109. doi: 10.1016/j.apsb.2020.10.005. Epub 2020 Oct 13. Acta Pharm Sin B. 2020. PMID: 33304780 Free PMC article. Review.
An overview of vaccine development for COVID-19.
Shahcheraghi SH, Ayatollahi J, Aljabali AA, Shastri MD, Shukla SD, Chellappan DK, Jha NK, Anand K, Katari NK, Mehta M, Satija S, Dureja H, Mishra V, Almutary AG, Alnuqaydan AM, Charbe N, Prasher P, Gupta G, Dua K, Lotfi M, Bakshi HA, Tambuwala MM. Shahcheraghi SH, et al. Among authors: satija s. Ther Deliv. 2021 Mar;12(3):235-244. doi: 10.4155/tde-2020-0129. Epub 2021 Feb 24. Ther Deliv. 2021. PMID: 33624533 Free PMC article. Review.
MicroRNAs as Biomarker for Breast Cancer.
Aggarwal T, Wadhwa R, Gupta R, Paudel KR, Collet T, Chellappan DK, Gupta G, Perumalsamy H, Mehta M, Satija S, Hansbro PM, Dua K, Maurya PK. Aggarwal T, et al. Among authors: satija s. Endocr Metab Immune Disord Drug Targets. 2020;20(10):1597-1610. doi: 10.2174/1871530320666200428113051. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 32342824 Review.
Potential anti-epileptic phytoconstituents: An updated review.
Kaur J, Famta P, Famta M, Mehta M, Satija S, Sharma N, Vyas M, Khatik GL, Chellappan DK, Dua K, Khurana N. Kaur J, et al. Among authors: satija s. J Ethnopharmacol. 2021 Mar 25;268:113565. doi: 10.1016/j.jep.2020.113565. Epub 2020 Nov 7. J Ethnopharmacol. 2021. PMID: 33166627 Review.
Hypoxia-Inducible Factor (HIF): Fuel for Cancer Progression.
Satija S, Kaur H, Tambuwala MM, Sharma P, Vyas M, Khurana N, Sharma N, Bakshi HA, Charbe NB, Zacconi FC, Aljabali AA, Nammi S, Dureja H, Singh TG, Gupta G, Dhanjal DS, Dua K, Chellappan DK, Mehta M. Satija S, et al. Curr Mol Pharmacol. 2021;14(3):321-332. doi: 10.2174/1874467214666210120154929. Curr Mol Pharmacol. 2021. PMID: 33494692 Review.
Pharmacological Properties of Bergapten: Mechanistic and Therapeutic Aspects.
Quetglas-Llabrés MM, Quispe C, Herrera-Bravo J, Catarino MD, Pereira OR, Cardoso SM, Dua K, Chellappan DK, Pabreja K, Satija S, Mehta M, Sureda A, Martorell M, Satmbekova D, Yeskaliyeva B, Sharifi-Rad J, Rasool N, Butnariu M, Bagiu IC, Bagiu RV, Calina D, Cho WC. Quetglas-Llabrés MM, et al. Among authors: satija s. Oxid Med Cell Longev. 2022 Apr 25;2022:8615242. doi: 10.1155/2022/8615242. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35509838 Free PMC article. Retracted. Review.
COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.
Aljabali AAA, Bakshi HA, Satija S, Metha M, Prasher P, Ennab RM, Chellappan DK, Gupta G, Negi P, Goyal R, Sharma A, Mishra V, Dureja H, Dua K, Tambuwala MM. Aljabali AAA, et al. Among authors: satija s. Pharm Nanotechnol. 2020;8(4):323-353. doi: 10.2174/2211738508999200817163335. Pharm Nanotechnol. 2020. PMID: 32811406 Review.
Gene Therapy for Neuropsychiatric Disorders: Potential Targets and Tools.
Shahcheraghi SH, Ayatollahi J, Lotfi M, Aljabali AAA, Al-Zoubi MS, Panda PK, Mishra V, Satija S, Charbe NB, Serrano-Aroca Á, Bahar B, Takayama K, Goyal R, Bhatia A, Almutary AG, Alnuqaydan AM, Mishra Y, Negi P, Courtney A, McCarron PA, Bakshi HA, Tambuwala MM. Shahcheraghi SH, et al. Among authors: satija s. CNS Neurol Disord Drug Targets. 2023;22(1):51-65. doi: 10.2174/1871527321666220304153719. CNS Neurol Disord Drug Targets. 2023. PMID: 35249508 Review.
180 results